Aehr Test Systems Toekomstige groei

Future criteriumcontroles 2/6

Aehr Test Systems zal naar verwachting zijn omzet verhogen met 27.3% per jaar.

Belangrijke informatie

n/a

Groei van de winst

n/a

Groei van de winst per aandeel

Semiconductor winstgroei	27.2%
Inkomstengroei	27.3%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	01 Nov 2024

Recente toekomstige groei-updates

Recent updates

Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper Position

Dec 17

Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks Justified

Dec 17

Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They Seem

Oct 23

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The Market

Oct 19

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Jun 06

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

May 01

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

Apr 18

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Apr 01

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Feb 21

Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)

Feb 14

Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?

Feb 01

Aehr Test Systems: Revised Guidance Likely To Be Lowered Again - Sell

Jan 11

Aehr Test Systems' (NASDAQ:AEHR) Shareholders Might Be Looking For Exit

Jan 03

Does Aehr Test Systems (NASDAQ:AEHR) Deserve A Spot On Your Watchlist?

Dec 16

Aehr Test Systems (NASDAQ:AEHR) Is Very Good At Capital Allocation

Oct 17

Calculating The Fair Value Of Aehr Test Systems (NASDAQ:AEHR)

Sep 13

Here's Why We Think Aehr Test Systems (NASDAQ:AEHR) Might Deserve Your Attention Today

Aug 09

The Return Trends At Aehr Test Systems (NASDAQ:AEHR) Look Promising

Jul 05

Is It Too Late To Consider Buying Aehr Test Systems (NASDAQ:AEHR)?

Jun 17

Investors Interested In Aehr Test Systems' (NASDAQ:AEHR) Earnings

May 16

If EPS Growth Is Important To You, Aehr Test Systems (NASDAQ:AEHR) Presents An Opportunity

Apr 30

Returns On Capital Are Showing Encouraging Signs At Aehr Test Systems (NASDAQ:AEHR)

Apr 03

We Ran A Stock Scan For Earnings Growth And Aehr Test Systems (NASDAQ:AEHR) Passed With Ease

Jan 15

Winst- en omzetgroeiprognoses

NasdaqCM:AEHR - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
5/31/2027	126	N/A	N/A	N/A	1
5/31/2026	92	N/A	N/A	N/A	1
5/31/2025	71	N/A	N/A	N/A	2
8/30/2024	59	29	0	0	N/A
5/31/2024	66	33	1	2	N/A
2/29/2024	72	15	5	6	N/A
11/30/2023	82	21	6	8	N/A
8/31/2023	75	19	7	8	N/A
5/31/2023	65	15	9	10	N/A
2/28/2023	63	14	3	3	N/A
11/30/2022	61	12	1	2	N/A
8/31/2022	56	9	5	5	N/A
5/31/2022	51	9	1	2	N/A
2/28/2022	38	4	2	2	N/A
11/30/2021	28	1	5	5	N/A
8/31/2021	20	-1	-2	-1	N/A
5/31/2021	17	-2	-3	-3	N/A
2/28/2021	13	-5	-4	-4	N/A
11/30/2020	14	-4	-4	-4	N/A
8/31/2020	19	-2	-1	-1	N/A
5/31/2020	22	-3	-2	-2	N/A
2/29/2020	26	0	-2	-1	N/A
11/30/2019	23	-3	-3	-3	N/A
8/31/2019	22	-4	-5	-5	N/A
5/31/2019	21	-5	-6	-6	N/A
2/28/2019	21	-5	-3	-3	N/A
11/30/2018	25	-2	-3	-2	N/A
8/31/2018	27	-1	1	2	N/A
5/31/2018	30	1	N/A	-1	N/A
2/28/2018	29	0	N/A	-3	N/A
11/30/2017	24	-3	N/A	-5	N/A
8/31/2017	21	-5	N/A	-10	N/A
5/31/2017	19	-6	N/A	-4	N/A
2/28/2017	14	-8	N/A	-6	N/A
11/30/2016	13	-8	N/A	-4	N/A
8/31/2016	13	-8	N/A	-3	N/A
5/31/2016	15	-7	N/A	-6	N/A
2/29/2016	15	-6	N/A	-5	N/A
11/30/2015	15	-4	N/A	-5	N/A
8/31/2015	13	-5	N/A	-4	N/A
5/31/2015	10	-7	N/A	-2	N/A
2/28/2015	14	-5	N/A	-2	N/A
11/30/2014	17	-3	N/A	-2	N/A
8/31/2014	19	0	N/A	-1	N/A
5/31/2014	20	0	N/A	-1	N/A
2/28/2014	18	-1	N/A	0	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er zijn onvoldoende gegevens om te bepalen of de verwachte winstgroei van AEHR boven de spaarquote ( 2.6% ) ligt.

Winst versus markt: Er zijn onvoldoende gegevens om te bepalen of de winst van AEHR naar verwachting sneller zal groeien dan de markt US

Hoge groeiwinsten: Er zijn onvoldoende gegevens om te bepalen of de winst van AEHR naar verwachting de komende 3 jaar aanzienlijk zal groeien.

Omzet versus markt: De omzet van AEHR ( 27.3% per jaar) zal naar verwachting sneller groeien dan de markt US ( 9.1% per jaar).

Hoge groei-inkomsten: De omzet van AEHR ( 27.3% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van AEHR naar verwachting over 3 jaar hoog zal zijn

Ontdek groeibedrijven

Bedrijfsanalyse en status van financiële gegevens

Gegevens	Laatst bijgewerkt (UTC-tijd)
Bedrijfsanalyse	2024/12/17 14:50
Aandelenkoers aan het einde van de dag	2024/12/17 00:00
Inkomsten	2024/08/30
Jaarlijkse inkomsten	2024/05/31

Gegevensbronnen

De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.

Pakket	Gegevens	Tijdframe	Voorbeeld Amerikaanse bron ^*
Financiële gegevens bedrijf	10 jaar	Resultatenrekening Kasstroomoverzicht Balans	SEC-formulier 10-K SEC-formulier 10-Q
Consensus schattingen analisten	+3 jaar	Financiële prognoses Koersdoelen analisten	Onderzoeksrapporten van analisten Blue Matrix
Marktprijzen	30 jaar	Aandelenprijzen Dividenden, splitsingen en acties	ICE Marktgegevens SEC-formulier S-1
Eigendom	10 jaar	Top aandeelhouders Handel met voorkennis	SEC-formulier 4 SEC-formulier 13D
Beheer	10 jaar	Leiderschapsteam Raad van bestuur	SEC-formulier 10-K SEC-formulier DEF 14A
Belangrijkste ontwikkelingen	10 jaar	Bedrijfsaankondigingen	SEC-formulier 8-K

^* voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige regelgevingsformulieren en bronnen gebruikt.

Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Lees hier meer.

Analysemodel en Snowflake

Details van het analysemodel dat is gebruikt om dit rapport te genereren, zijn beschikbaar op onze Github-pagina. We hebben ook handleidingen voor het gebruik van onze rapporten en tutorials op Youtube.

Leer meer over het team van wereldklasse dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.

Industrie en sector

Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op .

Bronnen van analisten

Aehr Test Systems, Inc. wordt gevolgd door 2 analisten. 2 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.

Analist	Instelling
Christian Schwab	Craig-Hallum Capital Group LLC
Jonathan Dorsheimer	William Blair & Company L.L.C.

Aehr Test Systems Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Price target increased by 108% to US$25.00

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems Provides Earnings Guidance for the Year 2024

Recent updates

Aehr Test Systems: With A Turnaround In Sight, It's High On My Watchlist To Build A Proper Position

Improved Earnings Required Before Aehr Test Systems, Inc. (NASDAQ:AEHR) Stock's 34% Jump Looks Justified

Investor sentiment improves as stock rises 17%

Gewirtz & Grossman LLC Notifies Class Action Lawsuit Filed Against Aehr Test Systems, Inc

Investor sentiment deteriorates as stock falls 17%

Aehr Test Systems' (NASDAQ:AEHR) Earnings Might Not Be As Promising As They Seem

Aehr Test Systems, Inc.'s (NASDAQ:AEHR) Shares Bounce 30% But Its Business Still Trails The Market

Aehr Test Systems, Inc. has filed a Follow-on Equity Offering in the amount of $40 million.

First quarter 2025 earnings released: EPS: US$0.023 (vs US$0.16 in 1Q 2024)

Aehr Test Systems, Inc. Reaffirms Earnings Guidance for the Fiscal Year Ending May 30, 2025

Aehr Test Systems: Enthusiastic Management But Weak Near-Term Prospects, Hold

Aehr Test Systems, Inc. to Report Q1, 2025 Results on Oct 10, 2024

Aehr Test Systems, Inc., Annual General Meeting, Oct 21, 2024

Aehr Test Systems (NASDAQ:AEHR) Is Experiencing Growth In Returns On Capital

Investor sentiment deteriorates as stock falls 19%

Independent Director recently sold US$186k worth of stock

Price target increased by 108% to US$25.00

Full year 2024 earnings released: EPS: US$1.15 (vs US$0.52 in FY 2023)

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Aehr Test Systems' (NASDAQ:AEHR) 27% Share Price Surge Not Quite Adding Up

Aehr Test Systems (NasdaqCM:AEHR) agreed to acquire Incal Technology, Inc for $23.1.

Investor sentiment improves as stock rises 40%

Aehr Test Systems to Report Q4, 2024 Results on Jul 16, 2024

Now 23% overvalued

Investor sentiment deteriorates as stock falls 18%

Now 20% overvalued

New minor risk - Share price stability

Aehr Test Systems: The Bottom Might Be In

We Like These Underlying Return On Capital Trends At Aehr Test Systems (NASDAQ:AEHR)

Investor sentiment improves as stock rises 15%

Insufficient new directors

Why Aehr Test Systems (NASDAQ:AEHR) Could Be Worth Watching

Now 24% overvalued

Aehr Test Systems' (NASDAQ:AEHR) Solid Earnings May Rest On Weak Foundations

New major risk - Revenue and earnings growth

Third quarter 2024 earnings released: US$0.051 loss per share (vs US$0.15 profit in 3Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Some Confidence Is Lacking In Aehr Test Systems (NASDAQ:AEHR) As Shares Slide 30%

Investor sentiment deteriorates as stock falls 15%

Aehr Test Systems to Report Q3, 2024 Results on Apr 09, 2024

Investor sentiment deteriorates as stock falls 16%

Investors Shouldn't Overlook Aehr Test Systems' (NASDAQ:AEHR) Impressive Returns On Capital

Aehr Test Systems Faces Cyclical Headwinds (Rating Downgrade)

Investor sentiment improves as stock rises 17%

Founder & Independent Chairman exercised options to buy US$310k worth of stock.

Should You Investigate Aehr Test Systems (NASDAQ:AEHR) At US$14.85?

President recently sold US$85k worth of stock

President notifies of intention to sell stock

Aehr Test Systems: Revised Guidance Likely To Be Lowered Again - Sell

Second quarter 2024 earnings released: EPS: US$0.21 (vs US$0.14 in 2Q 2023)

Aehr Test Systems Provides Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems' (NASDAQ:AEHR) Shareholders Might Be Looking For Exit

Does Aehr Test Systems (NASDAQ:AEHR) Deserve A Spot On Your Watchlist?

Investor sentiment deteriorates as stock falls 22%

Aehr Test Systems Announces Resignation of Rhea J. Posedel from Corporate Governance and Nominating Committee

Investor sentiment deteriorates as stock falls 21%

Aehr Test Systems (NASDAQ:AEHR) Is Very Good At Capital Allocation

First quarter 2024 earnings released: EPS: US$0.16 (vs US$0.022 in 1Q 2023)

Aehr Test Systems Reiterates Earnings Guidance for the Fiscal Year Ending May 31, 2024

Aehr Test Systems to Report Q1, 2024 Results on Oct 05, 2023

Aehr Test Systems, Annual General Meeting, Oct 23, 2023

Calculating The Fair Value Of Aehr Test Systems (NASDAQ:AEHR)

Full year 2023 earnings released: EPS: US$0.52 (vs US$0.36 in FY 2022)

Investor sentiment deteriorates as stock falls 18%

Here's Why We Think Aehr Test Systems (NASDAQ:AEHR) Might Deserve Your Attention Today

Independent Director notifies of intention to sell stock

Independent Director notifies of intention to sell stock

President recently sold US$6.3m worth of stock

President notifies of intention to sell stock